Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
What mattered in AI on Wednesday, September 23, 2026 — curated from 15+ sources.
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Hello HN! I've spent years debugging Windows crashes with tools that were either friendly but limited (e.g. Visual Studio) or powerful but archaic (e.g. WinDbg). I developed patterns and methods for…
The report suggests that greater exposure will not resolve the unease around the technology, nor reduce public support for AI regulation.
Marking two years of OpenAI Academy and bringing AI skills to even more communities.
Built directly into the YouTube Music app, Ask Music lets users describe what they want to hear in everyday language rather than searching for individual songs or artists.
YouTube’s new custom feeds let users describe the videos they want to see in their own words, then use Gemini to build a personalized feed around the request.
Diffusion Large Language Models (dLLMs) have recently emerged as a promising alternative to autoregressive LLMs by enabling non-autoregressive text generation. However, their practical deployment remains limited by inef…
Forwarded this? Get your own copy.
The one story that matters, 5 headlines and the paper everyone's citing — every Tuesday, free.
Subscribe free